Total Payments
$314,689
2024 Payments
$77,178
Companies
35
Transactions
534
Medicare Patients
1,265
Medicare Billing
$85,365
Payment Breakdown by Category
Other$272,950 (86.7%)
Consulting$22,425 (7.1%)
Food & Beverage$10,827 (3.4%)
Travel$8,336 (2.6%)
Education$135.84 (0.0%)
Gifts$14.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $272,950 | 122 | 86.7% |
| Consulting Fee | $22,425 | 9 | 7.1% |
| Food and Beverage | $10,827 | 351 | 3.4% |
| Travel and Lodging | $8,336 | 47 | 2.6% |
| Education | $135.84 | 4 | 0.0% |
| Gift | $14.99 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $307,086 | 348 | $0 (2024) |
| ViiV Healthcare Company | $3,493 | 2 | $0 (2019) |
| INTUITIVE SURGICAL, INC. | $754.38 | 3 | $0 (2024) |
| Grifols USA, LLC | $529.16 | 38 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $526.45 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $513.46 | 36 | $0 (2024) |
| Genentech USA, Inc. | $262.60 | 10 | $0 (2024) |
| Pulmonx Corporation | $201.16 | 2 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $197.60 | 5 | $0 (2023) |
| Circassia Pharmaceuticals Inc | $112.13 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $77,178 | 101 | GlaxoSmithKline, LLC. ($75,989) |
| 2023 | $79,751 | 79 | GlaxoSmithKline, LLC. ($79,460) |
| 2022 | $47,583 | 57 | GlaxoSmithKline, LLC. ($47,238) |
| 2021 | $51,047 | 43 | GlaxoSmithKline, LLC. ($50,957) |
| 2020 | $39,481 | 41 | GlaxoSmithKline, LLC. ($39,146) |
| 2019 | $17,968 | 97 | GlaxoSmithKline, LLC. ($13,710) |
| 2018 | $893.03 | 68 | GlaxoSmithKline, LLC. ($328.71) |
| 2017 | $789.31 | 48 | GlaxoSmithKline, LLC. ($257.26) |
All Payment Transactions
534 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $79.05 | General |
| Category: SURGERY | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Immunology | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $131.32 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $660.34 | General |
| Category: SURGERY | ||||||
| 09/14/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Gift | In-kind items and services | $14.99 | General |
| Category: SURGERY | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 08/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,625.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Respiratory | ||||||
| 08/16/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $5.85 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 267 | 286 | $50,548 | $17,416 |
| 2022 | 10 | 303 | 323 | $52,272 | $18,791 |
| 2021 | 9 | 274 | 323 | $66,653 | $25,776 |
| 2020 | 9 | 421 | 451 | $71,284 | $23,382 |
Total Patients
1,265
Total Services
1,383
Medicare Billing
$85,365
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $12,084 | $4,005 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 44 | $10,692 | $3,879 | 36.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 13 | $5,473 | $2,149 | 39.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 50 | 50 | $5,300 | $1,885 | 35.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 44 | 44 | $4,444 | $1,583 | 35.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 57 | 57 | $6,270 | $1,485 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 23 | $3,956 | $1,392 | 35.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 17 | $2,329 | $1,037 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $10,612 | $3,833 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 33 | $7,281 | $2,920 | 40.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 13 | 16 | $7,112 | $2,562 | 36.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 42 | 43 | $4,964 | $1,724 | 34.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 31 | $4,287 | $1,702 | 39.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 42 | 43 | $4,343 | $1,676 | 38.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 53 | 57 | $6,312 | $1,625 | 25.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $3,397 | $1,353 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $2,297 | $926.30 | 40.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 13 | 14 | $1,181 | $292.10 | 24.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 12 | 12 | $288.00 | $105.43 | 36.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 11 | 11 | $198.00 | $71.31 | 36.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 21 | 44 | $20,592 | $7,459 | 36.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 54 | $11,016 | $5,099 | 46.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $9,920 | $3,768 | 38.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 49 | $6,811 | $2,692 | 39.5% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 35 | 35 | $4,098 | $1,414 | 34.5% |
About Dr. Erica Gregonis, MD
Dr. Erica Gregonis, MD is a Internal Medicine healthcare provider based in Richmond, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1326242991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erica Gregonis, MD has received a total of $314,689 in payments from pharmaceutical and medical device companies, with $77,178 received in 2024. These payments were reported across 534 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($272,950).
As a Medicare-enrolled provider, Gregonis has provided services to 1,265 Medicare beneficiaries, totaling 1,383 services with total Medicare billing of $85,365. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Richmond, KY
- Active Since 06/14/2007
- Last Updated 12/09/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1326242991
Products in Payments
- AREXVY (Drug) $102,445
- TRELEGY ELLIPTA (Drug) $97,521
- NUCALA (Biological) $37,727
- ANORO ELLIPTA (Drug) $8,589
- ANORO (Drug) $5,535
- Da Vinci Surgical System (Device) $754.38
- Prolastin-C Liquid (Biological) $436.55
- OFEV (Drug) $272.63
- Pulmonx Endobronchial Valve EBV (Device) $201.16
- FASENRA (Drug) $152.70
- BREO (Drug) $143.48
- Xolair (Biological) $136.09
- STIOLTO RESPIMAT (Drug) $127.12
- DUPIXENT (Biological) $122.85
- FASENRA (Biological) $112.46
- ACTHAR (Biological) $108.54
- TEZSPIRE (Biological) $94.59
- Prolastin-C (Biological) $92.61
- BREZTRI (Drug) $81.18
- TUDORZA PRESSAIR (Drug) $75.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond
Dr. George Vetrovec, M.d, M.D
Internal Medicine — Payments: $3.2M
Internal Medicine $3.2M
Dr. Arun Sanyal, M.d, M.D
Internal Medicine — Payments: $956,666
Internal Medicine $956,666
Dr. Lawrence Schwartz, M.d, M.D
Internal Medicine — Payments: $205,580
Internal Medicine $205,580
Dr. Wally Smith, M.d, M.D
Internal Medicine — Payments: $195,657
Internal Medicine $195,657
Dr. Gaurav Gupta, Md, MD
Internal Medicine — Payments: $189,406
Internal Medicine $189,406
Dr. Andrew Poklepovic, M.d, M.D
Internal Medicine — Payments: $112,763
Internal Medicine $112,763